GLP-1 receptor agonists: differentiation within the class.

Lancet Diabetes Endocrinol · 2018

Last updated 2026-05-28

Journal	Lancet Diabetes Endocrinol, 2018
Citations	29
Relative citation ratio	1.05
NIH percentile	52
Molecules	—
Conditions studied	Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease

Full record and abstract on PubMed 29221658 ↗